Member-only story
Cancer in the News#12: Covid vaccines & cancer, Diet, Blood monitoring, Rising cancer rates, Less chemo, New chemos
12/21/20: 12th issue, Contents:
• COVID-19 Vaccines and Cancer Patients: 4 Things to Know
• CTCs Predict Overall Survival in Metastatic Breast Cancer
• Greater Adherence to a Diet for Diabetes Reduction May Improve Survival for Breast Cancer
• Cancer Rates on the Rise in Adolescents and Young Adults
• Neratinib Leads to Fewer Deaths, CNS Benefit, Potential OS Improvement in Early-Stage HER2+ Breast Cancer
• Ribociclib Continues to Showcase Significant Survival Benefit in HR+/HER2– Breast Cancer
• GP2/GM-CSF Combo Elicits 100% DFS Rate in HER2 3+ Breast Cancer at 5 Years
• FDA Approves Margetuximab-cmkb Plus Chemo in Pretreated Metastatic HER2+ Breast Cancer
• Tucatinib Triplet Prolongs Time to Deterioration of HRQoL in HER2+ Metastatic Breast Cancer With Brain Mets
• RxPONDER: Even More Women May Forgo Chemo for Breast Cancer
